• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

FDA reports initial 'no signal' for stroke risk with Pfizer boosters, launches...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 27, 2023 at 10:32: AM
via The FDA hasn’t detected any potential safety signals, including for stroke, in people aged 65 years and older who have received Pfizer’s bivalent Covid booster, one senior official told members of the agency’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Thursday.

article source
 

<



Similar threads

cafead
PTC Reports Positive Phase II Huntington’s Data, FDA Lifts Partial Clinical Hold
Replies
0
Views
27
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA clears Neuralink&#039;s brain chip implant in second patient, WSJ reports
Replies
0
Views
51
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Aldeyra Therapeutics reports that FDA rejects eye cancer drug
Replies
0
Views
180
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Steep drop in medical device reports on Bayer&#039;s Essure in 2021, FDA data show
Replies
0
Views
281
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA reports rare complications with Pfizer COVID vaccine, updates J&amp;J safety info
Replies
0
Views
294
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote